| Jose Ignacio Uribe, MD | |
|
3445 High Point Blvd, Suite 100, Bethlehem, PA 18017-7809 | |
| (610) 866-5555 | |
| (610) 866-2006 |
| Full Name | Jose Ignacio Uribe |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 40 Years |
| Location | 3445 High Point Blvd, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962660266 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | MD434423 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Physician Group Inc | 6709798333 | 1739 |
| Specialty Physician Associates, Llc | 6204012016 | 38 |
News Archive
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics.
AstraZeneca today announced BRILIQUE, a new oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines for Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation."
In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the California Maternal Quality Care Collaborative, based at Stanford University, Palo Alto, Ca., will present Reduction of Severe Maternal Morbidity from Hemorrhage (SMM-HEM) Using a State-Wide Perinatal Collaborative.
Cell Therapeutics, Inc. ("CTI") announced today that, following discussions with the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"), the CHMP may issue an opinion on CTI's Marketing Authorization Application ("MAA") for Pixuvri in mid-February.
You could call this a neat discovery. Researchers at the University of Alabama at Birmingham have found that a tissue-specific, non-coding RNA called NEAT1 has a major, previously undescribed role in memory formation.
› Verified 9 days ago
| Entity Name | Sacred Heart Healthcare System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740241421 PECOS PAC ID: 4082528161 Enrollment ID: O20031113000348 |
News Archive
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics.
AstraZeneca today announced BRILIQUE, a new oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines for Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation."
In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the California Maternal Quality Care Collaborative, based at Stanford University, Palo Alto, Ca., will present Reduction of Severe Maternal Morbidity from Hemorrhage (SMM-HEM) Using a State-Wide Perinatal Collaborative.
Cell Therapeutics, Inc. ("CTI") announced today that, following discussions with the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"), the CHMP may issue an opinion on CTI's Marketing Authorization Application ("MAA") for Pixuvri in mid-February.
You could call this a neat discovery. Researchers at the University of Alabama at Birmingham have found that a tissue-specific, non-coding RNA called NEAT1 has a major, previously undescribed role in memory formation.
› Verified 9 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics.
AstraZeneca today announced BRILIQUE, a new oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines for Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation."
In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the California Maternal Quality Care Collaborative, based at Stanford University, Palo Alto, Ca., will present Reduction of Severe Maternal Morbidity from Hemorrhage (SMM-HEM) Using a State-Wide Perinatal Collaborative.
Cell Therapeutics, Inc. ("CTI") announced today that, following discussions with the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"), the CHMP may issue an opinion on CTI's Marketing Authorization Application ("MAA") for Pixuvri in mid-February.
You could call this a neat discovery. Researchers at the University of Alabama at Birmingham have found that a tissue-specific, non-coding RNA called NEAT1 has a major, previously undescribed role in memory formation.
› Verified 9 days ago
| Entity Name | Specialty Physician Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487960639 PECOS PAC ID: 6204012016 Enrollment ID: O20110512000036 |
News Archive
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics.
AstraZeneca today announced BRILIQUE, a new oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines for Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation."
In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the California Maternal Quality Care Collaborative, based at Stanford University, Palo Alto, Ca., will present Reduction of Severe Maternal Morbidity from Hemorrhage (SMM-HEM) Using a State-Wide Perinatal Collaborative.
Cell Therapeutics, Inc. ("CTI") announced today that, following discussions with the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"), the CHMP may issue an opinion on CTI's Marketing Authorization Application ("MAA") for Pixuvri in mid-February.
You could call this a neat discovery. Researchers at the University of Alabama at Birmingham have found that a tissue-specific, non-coding RNA called NEAT1 has a major, previously undescribed role in memory formation.
› Verified 9 days ago
| Entity Name | Star Community Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033686159 PECOS PAC ID: 7618215237 Enrollment ID: O20190206002009 |
News Archive
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics.
AstraZeneca today announced BRILIQUE, a new oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines for Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation."
In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the California Maternal Quality Care Collaborative, based at Stanford University, Palo Alto, Ca., will present Reduction of Severe Maternal Morbidity from Hemorrhage (SMM-HEM) Using a State-Wide Perinatal Collaborative.
Cell Therapeutics, Inc. ("CTI") announced today that, following discussions with the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"), the CHMP may issue an opinion on CTI's Marketing Authorization Application ("MAA") for Pixuvri in mid-February.
You could call this a neat discovery. Researchers at the University of Alabama at Birmingham have found that a tissue-specific, non-coding RNA called NEAT1 has a major, previously undescribed role in memory formation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jose Ignacio Uribe, MD 3445 High Point Blvd, Suite 100, Bethlehem, PA 18017-7809 Ph: (610) 866-5555 | Jose Ignacio Uribe, MD 3445 High Point Blvd, Suite 100, Bethlehem, PA 18017-7809 Ph: (610) 866-5555 |
News Archive
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics.
AstraZeneca today announced BRILIQUE, a new oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines for Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation."
In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the California Maternal Quality Care Collaborative, based at Stanford University, Palo Alto, Ca., will present Reduction of Severe Maternal Morbidity from Hemorrhage (SMM-HEM) Using a State-Wide Perinatal Collaborative.
Cell Therapeutics, Inc. ("CTI") announced today that, following discussions with the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"), the CHMP may issue an opinion on CTI's Marketing Authorization Application ("MAA") for Pixuvri in mid-February.
You could call this a neat discovery. Researchers at the University of Alabama at Birmingham have found that a tissue-specific, non-coding RNA called NEAT1 has a major, previously undescribed role in memory formation.
› Verified 9 days ago
Narges Mazloom, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3445 High Point Blvd, Suite 400, Bethlehem, PA 18017 Phone: 610-866-5555 Fax: 610-866-3151 | |
Shriya Airen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017 Phone: 484-503-4005 | |
Dr. Aaron Jordon Jaworek, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017 Phone: 610-866-5555 Fax: 610-866-3151 | |
Andrew Pestcoe, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2597 Schoenersville Rd Ste 205, Bethlehem, PA 18017 Phone: 610-691-2552 Fax: 610-882-0445 | |
Glenn M Kaye, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2851 Baglyos Cir, Suite 201, Bethlehem, PA 18020 Phone: 610-867-7134 Fax: 610-867-7108 | |
Dr. Ahmad Issam Mahmoud Abualsoud, MBBCH Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017 Phone: 610-866-5555 Fax: 610-866-3151 | |
Maria Katherine Pomponio, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017 Phone: 484-503-4005 |